Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Fibrocell Science Inc (NASDAQ:FCSC)

2.04
Delayed Data
As of Mar 29
 -0.07 / -3.32%
Today’s Change
1.57
Today|||52-Week Range
11.33
+7.94%
Year-to-Date
No recent news for Fibrocell Science Inc.

Today’s Trading

Previous close2.11
Today’s open2.29
Day’s range2.03 - 2.29
Volume33,231
Average volume (3 months)62,178
Market cap$30.0M
Dividend yield--
Data as of 03/29/2017

Growth & Valuation

Earnings growth (last year)+54.12%
Earnings growth (this year)-16.24%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-27.85%
P/E ratioNM
Price/Sales77.98
Price/Book3.81

Competitors

 Today’s
change
Today’s
% change
CLRBCellectar Bioscience...+0.02+0.88%
RPRXRepros Therapeutics ...-0.00-0.41%
OCRXOcera Therapeutics I...+0.03+2.36%
CATBCatabasis Pharmaceut...+0.07+4.52%
Data as of 03/29/2017

Financials

Next reporting dateMay 16, 2017
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$355.0K
Annual profit (last year)-$15.3M
Net profit margin-4,307.61%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John M. Maslowski
Secretary &
VP-Business Administration
Sean D. Buckley
Corporate headquarters
Exton, Pennsylvania

Forecasts


Search for Jobs